- Section 1 - About the Company
- Ionis Pharmaceuticals Inc - Key Facts
- Ionis Pharmaceuticals Inc - Key Employees
- Ionis Pharmaceuticals Inc - Key Employee Biographies
- Ionis Pharmaceuticals Inc - Major Products and Services
- Ionis Pharmaceuticals Inc - History
- Ionis Pharmaceuticals Inc - Company Statement
- Ionis Pharmaceuticals Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Affiliate
- Section 2 – Company Analysis
- Company Overview
- Ionis Pharmaceuticals Inc - Business Description
- R&D Overview
- Ionis Pharmaceuticals Inc - Corporate Strategy
- Ionis Pharmaceuticals Inc - SWOT Analysis
- SWOT Analysis - Overview
- Ionis Pharmaceuticals Inc - Strengths
- Ionis Pharmaceuticals Inc - Weaknesses
- Ionis Pharmaceuticals Inc - Opportunities
- Ionis Pharmaceuticals Inc - Threats
- Ionis Pharmaceuticals Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Ionis Pharmaceuticals Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Oct 23, 2024: Ionis to Hold Third Quarter 2024 Financial Results Webcast
- Aug 01, 2024: Ionis Announces Q2 2024 Results
- Jul 19, 2024: Ionis to Hold Second Quarter 2024 Financial Results Webcast
- May 07, 2024: Ionis Reports First Quarter 2024 Financial Results
- Apr 25, 2024: Ionis Publishes 2023 Corporate Responsibility Report
- Mar 28, 2024: Ionis to Hold Olezarsen Phase 3 Data Webcast
- Feb 29, 2024: Ionis Announces New Chief Global Product Strategy Officer to Lead Next Phase of Commercial Growth
- Feb 21, 2024: Ionis Reports Fourth Quarter and Full Year 2023 Financial Results
- Jan 08, 2024: Ionis Poised for Continued Momentum in 2024 with Product Launches and Key Advances in Robust Pipeline of Investigational Medicines for Serious Diseases
- Dec 14, 2023: Ionis announces the appointment of Michael Yang to Board of Directors
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Ionis Pharmaceuticals Inc, Key Facts
- Ionis Pharmaceuticals Inc, Key Employees
- Ionis Pharmaceuticals Inc, Key Employees (cont..)
- Ionis Pharmaceuticals Inc, Key Employee Biographies
- Ionis Pharmaceuticals Inc, Major Products and Services
- Ionis Pharmaceuticals Inc, History
- Ionis Pharmaceuticals Inc, Other Locations
- Ionis Pharmaceuticals Inc, Subsidiaries
- Ionis Pharmaceuticals Inc, Affiliate
- Ionis Pharmaceuticals Inc, Key Competitors
- Ionis Pharmaceuticals Inc, Ratios based on current share price
- Ionis Pharmaceuticals Inc, Annual Ratios
- Ionis Pharmaceuticals Inc, Annual Ratios (Cont...1)
- Ionis Pharmaceuticals Inc, Annual Ratios (Cont...2)
- Ionis Pharmaceuticals Inc, Interim Ratios
- Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Ionis Pharmaceuticals Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Ionis Pharmaceuticals Inc, Performance Chart (2019 - 2023)
- Ionis Pharmaceuticals Inc, Ratio Charts
- Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Ionis Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook